Table 1 Comparison of baseline characteristics between the TASTE population and the non-randomized SCAAR population
From: Commentary: On the levels of patient selection in registry-based randomized controlled trials
Endpoint | Randomized patientsa (n = 7244) | Non-randomized patientsa (n = 4712) | Comparison of randomized and non-randomized patientsb | p valuec |
|---|---|---|---|---|
Age (years) (mean ± SD) | 66.2 (±11.6) | 68.8 (±12.8) | MD = 2.6 [2.1, 3.0] | < 0.001 |
Male sex (n (%)) | 5424/7244 (74.9) | 3201/4712 (67.9) | RD = −6.9% [−8.6, − 5.3] | < 0.001 |
Diabetes mellitus (n (%)) | 901/7244 (12.4) | 799/4712 (17.0) | RD = 4.5% [3.2, 5.8] | < 0.001 |
Current smoking (n (%)) | 2256/7244 (31.1) | 1198/4712 (25.4) | RD = − 5.7% [− 7.4, − 4.1] | < 0.001 |
Previous myocardial infarction (n (%)) | 842/7244 (11.6) | 836/4712 (17.7) | RD = 6.1% [4.8, 7.4] | < 0.001 |
Previous PCI (n (%)) | 699/7244 (9.7) | 572/4712 (12.1) | RD = 2.5% [1.3, 3.6] | < 0.001 |
Previous CABG (n (%)) | 144/7244 (2.0) | 233/4712 (4.9) | RD = 2.3%, [2.3, 3.7] | < 0.001 |
Fibrinolysis before PCI (n (%)) | 137/7244 (1.9) | 116/4712 (2.5) | RD = 0.6%, [0.0, 1.1] | 0.039 |
Killip class ≥ 2 (n (%)) | 481/7244 (6.6) | 794/4712 (16.9) | RD = 10.2%, [0.9, 11.4] | < 0.001 |
Radial-artery approach (n (%)) | 4809/7244 (66.4) | 2588/4712 (54.9) | RD = − 11.5% [− 13.3,-9.7] | < 0.001 |
Type of disease (n (%)) |  |  |  | < 0.001 |
 One-vessel disease | 3886/7244 (53.5) | 2192/4712 (46.5) | RD = − 7.1% [− 9.0, − 5.3] |  |
 Two-vessel disease | 2082/7244 (28.7) | 1258/4712 (26.7) | RD = − 2.0% [− 3.7, − 0.4] |  |
 Three-vessel disease | 1056/7244 (14.6) | 874/4712 (18.6) | RD = 4.0% [2.6, 5.3] |  |
 Left main coronary artery disease | 203/7244 (2.8) | 366/4712 (7.8) | RD = 5.0% [4.1, 5.8] |  |
 Data not available | 17/7244 (0.2) | 22/4712 (0.5) | RD = 0.2% [0.0, 0.4] |  |